Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium.
Franzoi MA, Ferreira AR, Lemaire A, Rodriguez J, Grosjean J, Ribeiro JM, Polastro L, Grellety T, Artignan X, Le Du K, Pagliuca M, Nouhaud É, Autheman M, André F, Basch E, Metzger O, Ferté C, Di Palma M, Scotté F, Vaz-Luis I. Franzoi MA, et al. Among authors: grosjean j. Lancet Reg Health Eur. 2024 Jul 31;44:101005. doi: 10.1016/j.lanepe.2024.101005. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444707 Free PMC article.
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain.
Blancas I, Grosjean J, Pedersini R, Buzzoni C, Sleilaty G, Molero A, Tamma A, Chouaki N, Atienza M, Emde A, Siddi S, Sanchez Bayona R, Del Mastro L, Fakhouri W. Blancas I, et al. Among authors: grosjean j. Future Oncol. 2024;20(31):2371-2384. doi: 10.1080/14796694.2024.2368455. Epub 2024 Aug 8. Future Oncol. 2024. PMID: 39115881 Free PMC article.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Bachelot T, et al. Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. Ann Oncol. 2019. PMID: 30796821 Free article. Clinical Trial.
Empowering healthcare education: A multilingual ontology for medical informatics and digital health (MIMO) integrated to artificial intelligence powered training in smart hospitals.
Benis A, Grosjean J, Disson F, Crisan-Vida M, Weber P, Stoicu-Tivadar L, Staccini P, Darmoni SJ. Benis A, et al. Among authors: grosjean j. Health Informatics J. 2024 Oct-Dec;30(4):14604582241287010. doi: 10.1177/14604582241287010. Health Informatics J. 2024. PMID: 39367798 Free article.
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism.
Hagege O, Brevet P, Gerard B, Duhamel E, Mihailescu SD, Alcaix D, Weber AJ, Marcelli C, Grosjean J, Varin R, Lequerré T, Vittecoq O. Hagege O, et al. Among authors: grosjean j. Clin Exp Rheumatol. 2024 Sep 17. doi: 10.55563/clinexprheumatol/6cxcaq. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 39360371
123 results